ArticleHemaSphere2024

Induction of AML cell differentiation using HOXA9/DNA binding inhibitors as a potential therapeutic option for HOXA9-dependent AML.

Mélanie Lambert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.